1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Plasma Therapeutics Revenue
• 1.4 Market by Type
  • 1.4.1 Global Plasma Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Human Serum Protein
  • 1.4.3 Plasma-Derived Clotting Factor
  • 1.4.4 Immunoglobulins
  • 1.4.5 High Immunoglobulins
• 1.5 Market by Application
  • 1.5.1 Global Plasma Therapeutics Market Share by Application: 2020 VS 2026
  • 1.5.2 Research Laboratories And Institutions
  • 1.5.3 Hospitals
  • 1.5.4 Stand-Alone Blood Banks
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Plasma Therapeutics Market Perspective (2015-2026)
• 2.2 Global Plasma Therapeutics Growth Trends by Regions
  • 2.2.1 Plasma Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Plasma Therapeutics Historic Market Share by Regions (2015-2020)
  • 2.2.3 Plasma Therapeutics Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Plasma Therapeutics Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Plasma Therapeutics Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Plasma Therapeutics Players by Market Size
  • 3.1.1 Global Top Plasma Therapeutics Players by Revenue (2015-2020)
  • 3.1.2 Global Plasma Therapeutics Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Plasma Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Plasma Therapeutics Market Concentration Ratio
  • 3.2.1 Global Plasma Therapeutics Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Plasma Therapeutics Revenue in 2019
• 3.3 Plasma Therapeutics Key Players Head office and Area Served
• 3.4 Key Players Plasma Therapeutics Product Solution and Service
• 3.5 Date of Enter into Plasma Therapeutics Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Plasma Therapeutics Historic Market Size by Type (2015-2020)
• 4.2 Global Plasma Therapeutics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Plasma Therapeutics Market Size by Application (2015-2020)
• 5.2 Global Plasma Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Plasma Therapeutics Market Size (2015-2020)
• 6.2 Plasma Therapeutics Key Players in North America (2019-2020)
• 6.3 North America Plasma Therapeutics Market Size by Type (2015-2020)
• 6.4 North America Plasma Therapeutics Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Plasma Therapeutics Market Size (2015-2020)
• 7.2 Plasma Therapeutics Key Players in Europe (2019-2020)
• 7.3 Europe Plasma Therapeutics Market Size by Type (2015-2020)
• 7.4 Europe Plasma Therapeutics Market Size by Application (2015-2020)

8 China

• 8.1 China Plasma Therapeutics Market Size (2015-2020)
• 8.2 Plasma Therapeutics Key Players in China (2019-2020)
• 8.3 China Plasma Therapeutics Market Size by Type (2015-2020)
• 8.4 China Plasma Therapeutics Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Plasma Therapeutics Market Size (2015-2020)
• 9.2 Plasma Therapeutics Key Players in Japan (2019-2020)
• 9.3 Japan Plasma Therapeutics Market Size by Type (2015-2020)
• 9.4 Japan Plasma Therapeutics Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Plasma Therapeutics Market Size (2015-2020)
• 10.2 Plasma Therapeutics Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Plasma Therapeutics Market Size by Type (2015-2020)
• 10.4 Southeast Asia Plasma Therapeutics Market Size by Application (2015-2020)

11 India

• 11.1 India Plasma Therapeutics Market Size (2015-2020)
• 11.2 Plasma Therapeutics Key Players in India (2019-2020)
• 11.3 India Plasma Therapeutics Market Size by Type (2015-2020)
• 11.4 India Plasma Therapeutics Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Plasma Therapeutics Market Size (2015-2020)
• 12.2 Plasma Therapeutics Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Plasma Therapeutics Market Size by Type (2015-2020)
• 12.4 Central & South America Plasma Therapeutics Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Baxter
  • 13.1.1 Baxter Company Details
  • 13.1.2 Baxter Business Overview
  • 13.1.3 Baxter Plasma Therapeutics Introduction
  • 13.1.4 Baxter Revenue in Plasma Therapeutics Business (2015-2020))
  • 13.1.5 Baxter Recent Development
• 13.2 CSL Behring
  • 13.2.1 CSL Behring Company Details
  • 13.2.2 CSL Behring Business Overview
  • 13.2.3 CSL Behring Plasma Therapeutics Introduction
  • 13.2.4 CSL Behring Revenue in Plasma Therapeutics Business (2015-2020)
  • 13.2.5 CSL Behring Recent Development
• 13.3 Grifols Therapeutics
  • 13.3.1 Grifols Therapeutics Company Details
  • 13.3.2 Grifols Therapeutics Business Overview
  • 13.3.3 Grifols Therapeutics Plasma Therapeutics Introduction
  • 13.3.4 Grifols Therapeutics Revenue in Plasma Therapeutics Business (2015-2020)
  • 13.3.5 Grifols Therapeutics Recent Development
• 13.4 Octapharma
  • 13.4.1 Octapharma Company Details
  • 13.4.2 Octapharma Business Overview
  • 13.4.3 Octapharma Plasma Therapeutics Introduction
  • 13.4.4 Octapharma Revenue in Plasma Therapeutics Business (2015-2020)
  • 13.4.5 Octapharma Recent Development
• 13.5 Abeona Therapeutics
  • 13.5.1 Abeona Therapeutics Company Details
  • 13.5.2 Abeona Therapeutics Business Overview
  • 13.5.3 Abeona Therapeutics Plasma Therapeutics Introduction
  • 13.5.4 Abeona Therapeutics Revenue in Plasma Therapeutics Business (2015-2020)
  • 13.5.5 Abeona Therapeutics Recent Development
• 13.6 ADMA Biologics
  • 13.6.1 ADMA Biologics Company Details
  • 13.6.2 ADMA Biologics Business Overview
  • 13.6.3 ADMA Biologics Plasma Therapeutics Introduction
  • 13.6.4 ADMA Biologics Revenue in Plasma Therapeutics Business (2015-2020)
  • 13.6.5 ADMA Biologics Recent Development
• 13.7 Amag Pharmaceuticals
  • 13.7.1 Amag Pharmaceuticals Company Details
  • 13.7.2 Amag Pharmaceuticals Business Overview
  • 13.7.3 Amag Pharmaceuticals Plasma Therapeutics Introduction
  • 13.7.4 Amag Pharmaceuticals Revenue in Plasma Therapeutics Business (2015-2020)
  • 13.7.5 Amag Pharmaceuticals Recent Development
• 13.8 Antares Pharma
  • 13.8.1 Antares Pharma Company Details
  • 13.8.2 Antares Pharma Business Overview
  • 13.8.3 Antares Pharma Plasma Therapeutics Introduction
  • 13.8.4 Antares Pharma Revenue in Plasma Therapeutics Business (2015-2020)
  • 13.8.5 Antares Pharma Recent Development
• 13.9 BioDelivery Sciences
  • 13.9.1 BioDelivery Sciences Company Details
  • 13.9.2 BioDelivery Sciences Business Overview
  • 13.9.3 BioDelivery Sciences Plasma Therapeutics Introduction
  • 13.9.4 BioDelivery Sciences Revenue in Plasma Therapeutics Business (2015-2020)
  • 13.9.5 BioDelivery Sciences Recent Development
• 13.10 Bio Products Laboratory
  • 13.10.1 Bio Products Laboratory Company Details
  • 13.10.2 Bio Products Laboratory Business Overview
  • 13.10.3 Bio Products Laboratory Plasma Therapeutics Introduction
  • 13.10.4 Bio Products Laboratory Revenue in Plasma Therapeutics Business (2015-2020)
  • 13.10.5 Bio Products Laboratory Recent Development
• 13.11 Biota Pharmaceuticals
  • 10.11.1 Biota Pharmaceuticals Company Details
  • 10.11.2 Biota Pharmaceuticals Business Overview
  • 10.11.3 Biota Pharmaceuticals Plasma Therapeutics Introduction
  • 10.11.4 Biota Pharmaceuticals Revenue in Plasma Therapeutics Business (2015-2020)
  • 10.11.5 Biota Pharmaceuticals Recent Development
• 13.12 Biotest Pharmaceuticals
  • 10.12.1 Biotest Pharmaceuticals Company Details
  • 10.12.2 Biotest Pharmaceuticals Business Overview
  • 10.12.3 Biotest Pharmaceuticals Plasma Therapeutics Introduction
  • 10.12.4 Biotest Pharmaceuticals Revenue in Plasma Therapeutics Business (2015-2020)
  • 10.12.5 Biotest Pharmaceuticals Recent Development
• 13.13 China Biologic Products
  • 10.13.1 China Biologic Products Company Details
  • 10.13.2 China Biologic Products Business Overview
  • 10.13.3 China Biologic Products Plasma Therapeutics Introduction
  • 10.13.4 China Biologic Products Revenue in Plasma Therapeutics Business (2015-2020)
  • 10.13.5 China Biologic Products Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer

Plasma Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Plasma Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Baxter
CSL Behring
Grifols Therapeutics
Octapharma
Abeona Therapeutics
ADMA Biologics
Amag Pharmaceuticals
Antares Pharma
BioDelivery Sciences
Bio Products Laboratory
Biota Pharmaceuticals
Biotest Pharmaceuticals
China Biologic Products

Market segment by Type, the product can be split into
Human Serum Protein
Plasma-Derived Clotting Factor
Immunoglobulins
High Immunoglobulins
Market segment by Application, split into
Research Laboratories And Institutions
Hospitals
Stand-Alone Blood Banks

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America